Jeroen Verhoeven
Department of Diagnostic Sciences
Ghent University
Jeroen Verhoeven has not added Biography.
If you are Jeroen Verhoeven and would like to personalize this page please email our Author Liaison for assistance.
Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
PloS one , 2017 | Pubmed ID: 28273180
Evaluating Hepatobiliary Transport with F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and and Performance.
Contrast media & molecular imaging , 2018 | Pubmed ID: 29853807
Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[F]FCA in mouse models of liver disease.
Nuclear medicine and biology Jan - Feb, 2019 | Pubmed ID: 30595544
The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review.
Frontiers in medicine , 2019 | Pubmed ID: 30761302
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.
Scientific reports Feb, 2019 | Pubmed ID: 30814660
Technical feasibility of [F]FET and [F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model.
Radiation oncology (London, England) May, 2019 | Pubmed ID: 31146757
PET quantification of [18F]MPPF in the canine brain using blood input and reference tissue modelling.
PloS one , 2019 | Pubmed ID: 31185062
Cost-Effectiveness of [F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma.
Frontiers in oncology , 2019 | Pubmed ID: 31555584
Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study.
PloS one , 2019 | Pubmed ID: 31634381
Kinetic analysis of [F] altanserin bolus injection in the canine brain using PET imaging.
BMC veterinary research Nov, 2019 | Pubmed ID: 31752848
2-[F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation.
Nuclear medicine and biology Mar - Apr, 2020 | Pubmed ID: 31841816
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [F]fluorophenylglutamine and [F]fluorobiphenylglutamine.
Nuclear medicine and biology Jul - Aug, 2020 | Pubmed ID: 32447069
Radiosynthesis, in vitro and preliminary biological evaluation of [ F]2-amino-4-((2-((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino)butanoic acid, a novel alanine serine cysteine transporter 2 inhibitor-based positron emission tomography tracer.
Journal of labelled compounds & radiopharmaceuticals 08, 2020 | Pubmed ID: 32472945
Development of a Rat Model for Glioma-Related Epilepsy.
International journal of molecular sciences Sep, 2020 | Pubmed ID: 32977526
Intra-individual dynamic comparison of F-PSMA-11 and Ga-PSMA-11 in LNCaP xenograft bearing mice.
Scientific reports 12, 2020 | Pubmed ID: 33273603
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.
Theranostics , 2021 | Pubmed ID: 34335972
Comparison of In Vivo and Ex Vivo Magnetic Resonance Imaging in a Rat Model for Glioblastoma-Associated Epilepsy.
Diagnostics (Basel, Switzerland) Jul, 2021 | Pubmed ID: 34441246
Impact of the molar activity and PSMA expression level on [F]AlF-PSMA-11 uptake in prostate cancer.
Scientific reports 11, 2021 | Pubmed ID: 34799653
Recent advancements in F-labeled PSMA targeting PET radiopharmaceuticals.
Nuclear medicine and biology Mar-Apr, 2022 | Pubmed ID: 34998217
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved